Healthcare IT Solution Market Opportunity
Pharma & Biotech
52
8
10
Voice-of-Customer Research
Go-to-Market Strategy
Competitive Analysis
Objective
A leading pharmaceutical & clinical diagnostics manufacturer wanted to understand the market opportunity for a novel multidisciplinary cancer conference IT support solution
Our Approach
Secondary Research
- Reviewed public filings (e.g., 10-K, earnings transcripts) of major client competitors to assess our client’s technology and market position
- Reviewed and summarized all existing IT solutions for cancer conference / tumor board management
Primary Research
- Conducted 52 in-depth stakeholder interviews with oncologists, IT administrators, and cancer care administrators to:
- Understand the current standard of practice around MCC workflow and identify future trends
- Characterize current and anticipated future oncology IT budget, procurement, and implementation behavior
- Determine the unmet needs and key trends in this space
Quantitative Analysis
- Developed a “bottoms-up” model to estimate the WW addressable market for a potential IT solution, including:
- Current (2016) and future (2021) WW market size estimates
- Segmentation across customer type, geography and payor type
Outcome
DeciBio delivered an in-person presentation to a cross-functional client team, with the results of the analysis input directly into the client’s strategic planning
Related Client Results
Global Companion Diagnostic Guideline Mapping and Strategy
Biomarker and Diagnostics Strategy
Go-to-Market Strategy
RWD Biobank Offering Go-to-Market Strategy
Voice-of-Customer Research
Go-to-Market Strategy
Pricing Strategy
Competitive Analysis
